vaccines
Based on insights gleaned from earlier trials of its Granite and Slate neoantigen immunotherapies, the company is improving the design of its vaccines and homing in on best responders.
IO Biotech Studying Cancer Vaccine With Merck's Keytruda in Advanced Melanoma Patients
The company will study the activity of IO102-IO103 with Merck's anti-PD-1 drug in advanced melanoma patients and look for biomarkers of response.
Elicio Therapeutics Begins Phase I/II Trial of Vaccine Against KRAS-Driven Tumors
In the study, researchers will enroll patients with a variety of KRAS-mutated cancers and establish minimal residual disease using ctDNA testing.
BostonGene, Abramson Cancer Center to Collaborate on Immunotherapy Studies
The agreement will support multiple research projects at UPenn, beginning with a study of tumor-specific antigens for personalized cancer vaccine development.
European Consortium Wins €6.9M Grant to Develop HPV16-Positive Cancer Vaccine
The consortium, led by a Belgium biotech, will use the funds to advance an mRNA-based vaccine as a treatment for head and neck, cervical, and anogenital cancers.